Loading…
Loading…
FIGS does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for FIGS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for FIGS and 80,000+ other tickers.
See exactly how FIGS's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FIGS and 80,000+ other tickers.
FIGS, Inc. functions as a direct-to-consumer enterprise specializing in healthcare apparel and lifestyle merchandise across the United States. The company innovates and distributes a comprehensive selection of medical uniforms, complemented by a diverse array of non-scrub items. These offerings span functional pieces like lab coats, under-scrubs, compression socks, footwear, and masks, extending to activewear, loungewear, and outerwear such as performance leggings, sports bras, various tops (including super-soft pima cotton options), vests, and jackets. Customers can access and purchase FIGS'…
Figs (FIGS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its third quarter 2026 financial results on Thursday, November 5, 2026, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a third quarter 202.
FIGS Inc. (FIGS) is rated BUY, supported by robust revenue growth, margin expansion, and a debt-free balance sheet enabling aggressive share repurchases. FIGS trades at a 23.8x forward EV/EBITDA premium, justified by A+ growth metrics and consensus EBITDA growth of 35% versus -1% for its closest peer. Recent 2Q26 results saw net revenue up 28.8% YoY, EBITDA margin expand 570 bps, and 70% of revenue driven by repeat customers.
Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.
FIGS is driving customer loyalty through innovative scrubs, improved fits and expanded apparel offerings, fueling stronger engagement and revenue growth.